Boston, MA -- (SBWIRE) -- 10/23/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: XSUNX, Inc.(OTCMKTS:XSNX), JPMorgan Chase & Co.(NYSE:JPM), AK Steel Holding Corporation(NYSE:AKS), Cell Therapeutics Inc(NASDAQ:CTIC).
XSUNX, Inc.(OTCMKTS:XSNX) opened its shares at the price of $0.03 for the day. Its closing price was $0.0187 after losing -21.76% for the day. The company traded with the total volume of 13.45 million shares, while its average trading volume remained 2.79 million shares. The beta of XSNX stands at 0.42.
XsunX, Inc. (XsunX) is developing and has begun to market a hybrid manufacturing solution to produce high performance Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Its processing technology, CIGSolar, focuses on the mass production of individual thin-film CIGS solar cells that match silicon solar cell dimensions.
Has XSNX Found The Bottom and Ready To Move Up? Find Out Here
JPMorgan Chase & Co.(NYSE:JPM) percentage change plunged -1.20% to close at $53.62 with the total traded volume of 24.82 million shares, and average volume of 22.11 million. The 52 week range of the stock remained $38.83 - $56.93, while its day lowest price was $53.62 and it hit its day highest price at $54.68
JPMorgan Chase & Co. (JPMorgan Chase) is a financial holding company. The Company is a global financial services firm and a banking institution in the United States, with global operations.
Has JPM Found The Bottom And Ready To Gain Momentum? Find Out Here
AK Steel Holding Corporation(NYSE:AKS) started its trading session with the price of $4.19 and closed at $3.98 by losing -1.97%. AKS stocks traded with total volume of 7.05 million shares, while the average trading volume remained 6.12 million shares. The beta of AKS stands at 2.52. Day range of the stock was $3.88 -$4.22.
AK Steel Holding Corporation (AK Holding) is an integrated producer of flat-rolled carbon, stainless and electrical steels and tubular products through its wholly-owned subsidiary, AK Steel Corporation (AK Steel and, together with AK Holding, the Company). The Company’s operations consist primarily of nine steelmaking and finishing plants and tubular production facilities located in Indiana, Kentucky, Ohio and Pennsylvania.
Why Should Investors Buy AKS After the Recent Fall? Just Go Here and Find Out
Cell Therapeutics Inc(NASDAQ:CTIC) ended its day with the gain of +3.87% and closed at the price of $1.88 after opening at $1.86. Stock traded during its last trading session with the total volume of 2.53 million shares, as compared to its average volume of 3.76 million shares.
Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need.
Why Should Investors Buy CTIC After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)